Autopsy report · NCT03550352

Cannabinoids in PLWHIV on Effective ART

“expiration of study product; end of study product availability”

The sponsor’s own words in the registry.

Life of this trial

• Registered 3 years 3 months before it started.
• Ran for about 9 months before it stopped.
• 10 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 2

Sponsor

McGill University Health Centre/Research Institute of the McGill University Health Centre

Sponsor type

University, hospital or other

Conditions

HIV Infections

Interventions

TN-TC11M2 oral capsules (THC 2.5 mg/CBD 2.5 mg); TN-C200M2 oral capsules (CBD 200 mg)

Participants

10

Sites

1

Countries

Canada

Trials that died the same way

• Polyphenon E in Treating Patients With High-Risk of Colorectal Cancer
  “pending expiration of the supply of study agent.” (73% match in meaning)
• Remote Trial - Tobacco Product Standard (VLNC)
  “Study determined to be not feasible at this time due to limited availability of study product and limited availability of study products in the marketplace.” (66% match in meaning)
• Feasibility and Impact of Volume Targeted Ventilation in the Delivery Room
  “Discontinuation of the study Product by manufacturer” (66% match in meaning)
• Optimal Timing of BR55 CEUS of the Ovaries
  “Sponsor decision; expiration of available study agent due to long recruitment timeline.” (66% match in meaning)
• Probiotic Supplementation in Preventing Treatment-Related Diarrhea in Patients With Cancer Undergoing Chemotherapy
  “issues with obtaining study product” (62% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.